FDA Approves IDE Study of BioPoly RS Partial Resurfacing Knee

BioPoly received FDA approval to conduct an Investigational Device Exemption clinical study of the BioPoly® RS Partial Resurfacing Knee, used in the treatment of cartilage lesions.

BioPoly material combines polymer and hyaluronic acid into a “self-lubricated” polymer that can carry physiological loads without causing damage to other knee...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us